Practice Guidelines, Position Statements, Surveys and Reports
Practice Guideline
| Document Title/Purpose | Date of Publication/Revision | Committee | Copyright | Download |
|---|---|---|---|---|
| Cytogenetic Analysis C: Recommendations for Analysis and Reporting of Cancer Specimens | February 2026 | Labratory Practice | CCMG | |
| Guideline for the Reporting of Significant Laboratory Results in Biochemical Genetics | Dec 2022 | Metabolics | CCMG | |
| Practice guidelines for BRCA1/2 tumour testing in ovarian cancer | Oct 2022 | Somatic BRCA WG | CCMG | |
| CCMG Guidelines For Retention of: A) Cytogenetic Specimens and Genetic Records B) Molecular Specimens and Genetic Records | Mar 2021 | Laboratory (Cytogenetics) | CCMG | |
| CF Testing / Screening. | Under revision | Laboratory (Molecular) | CCMG epub | |
| Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the CCMG | Feb 2021 | Fetal Exome WG | CCMG | |
| Cytogenetic Analysis B: Recommendations for the Indications, Analysis and Reporting of Constitutional Specimens. | Mar 2021 | Laboratory (Cytogenetics) | CCMG epub | |
| Cytogenetic FISH Guidelines (CLSI). | October 2021 | Laboratory (Cytogenetics) | CCMG | |
| DNA Banking. | Nov 2020 | Laboratory (Molecular) | CCMG epub | |
| Laboratory Guidelines for Next-Generation Sequencing | May 2019 | CCMG | CCMG | Link |
| Practice Guideline: Recommendations for the use of chromosome microarray for prenatal diagnosis in Canada | Mar 2018 | Prenatal Microarray (ad hoc) | CCMG/SOGC | Publication Link |
| No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes | Sept 2017 | CCMG/SOGC | ||
| Genomic Microarray Testing – CCMG Guidelines | Jan 2016 | Laboratory (Cytogenetics) | CCMG | |
| Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing | Aug 2016 | CCMG/SOGC | SOGC Journal | Publication Link |
| New CCMG ad hoc Examination Reform Committee – Final recommendations and implementation plan | Sep 2014 | Examination Reform (ad hoc) | CCMG | |
| Maintaining Competence For Laboratory Geneticists | Sept 2011 | Laboratory (General) | CCMG |
Position Statements
| Document Title/Purpose | Date of Publication | Committee | Copyright | Download |
|---|---|---|---|---|
| Reproductive carrier screening for genetic disorders: position statement of the Canadian College of Medical Geneticists | Aug 2025 | Reproductive Carrier Screening WG | CCMG | Link |
| Canadian consensus for the assessment and testing of Lynch syndrome | May 2025 | Canadian Lynch Syndrome (CDN-LS) WG | CCMG | Link |
| Position Statement on the Storage of Patient Genetic and Genomic Information in Electronic Health Records | January 2025 | E2P2 | CCMG | |
| Next generation of free? Points to consider when navigating sponsored genetic testing | November 2023 | Joint CCMG-CAGC Statement: Sponsored Genetic Testing in Canadian Health Care Working Group | CCMG | |
| Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists | January 2023 | CCMG Neurodevelopmental Disorders Working Group | CCMG | |
| Genetic Testing in Children | Feb 2022 | CPS | CPS | Link |
| Choosing Wisely Canada Choosing Wisely Canada – Set 2 | 2016 2022 | CCMG E2P2 Committee | CCMG | PDF PDF |
| Canadian College of Medical Geneticists and Canadian Association of Genetic Counsellors commentary to proposed Ontario Bill 225 and Ontario Bill 304 (Harvey and Gurvir’s Law 2020 and 2021, respectively) | Nov 2021 | CCMG – CAGC | CCMG – CAGC | PDF (English) PDF(French) |
| Points to Consider: Resuming Genetic Services in a Pandemic | Aug 2020 | CCMG E2P2 Committee | CCMG epub | |
| Genetic Non-Discrimination Act | Jun 2018 | CAGC | CAGC | |
| CCMG Statement on Germline Variant Classification | Apr 2017 | Column 3 Value 2 | CCMG | |
| The clinical application of genome-wide sequencing for monogenic diseases in Canada | May 2015 | CCMG | link | |
| CCMG Statement on Gene Patents | Oct 2012 | CCMG E2P2 Committee | Clinical Genetics | Link |
Surveys, Reports, Other
| Document Title/Purpose | Date of Publication | Committee | Copyright | Download |
|---|---|---|---|---|
| Biochemical Genetics TAT, Sample and Record Retention Survey results | Oct 2014 | CCMG Laboratory Practice Committee | CCMG | |
| Biochemical Genetics Lab Test Turn-Around Time and Sample/Record Retention Survey Performed and Summarized by: David Sinasac, PhD FCCMG |
Nov 2013 | CCMG Laboratory Practice Committee | CCMG | |
| Canadian Organization for Rare Disorders released Canada’s Strategy for Rare | CORD | CORD | ||
| Report on Preimplantation Genetic Diagnosis in Canada – Jan 2010 | ad hoc PGD | CCMG/SOGC, CFAS, CAGC | ||
| Tips & Tricks to Get Your Section 3 Credits | E2P2 | CCMG | ||
| Lab Practice Brochure | E2P2 | CCMG |
CCMG Policies & TORs
| Document Title/Purpose | Date of Publication | Committee | Copyright | Download |
|---|---|---|---|---|
| CCMG Travel Policy | Oct 2023 | BOD | CCMG | |
| CCMG Committees | Nov 2015 | BOD | CCMG | |
| CCMG Emeritus TOR | Mar 2017 | Nominations | CCMG | |
| CCMG Endorsement Policy | Dec 2018 | BOD | CCMG | |
| CCMG Leave of Absence Policy | Jan 2016 | BOD | CCMG | |
| CCMG Nomination Process | Jul 2019 | Nominations | CCMG | |
| CCMG Policy on Electronic Communication | Mar 2017 | BOD | CCMG | |
| CCMG Reinstatement Policy | Nov 2016 | BOD | CCMG | Policy Reinstatement Form |
| CCMG Letters of Support | Jul 2015 | Policies & Bylaws | CCMG | |
| CCMG Communication Policy | June 2023 | BoD | CCMG | |
| CCMG Professional and Ethical Guidelines | Oct 2023 | BoD | CCMG |
Genetic and Genomic Diagnostics (GGD) Training Program, Ad Hoc Working Group
*Restricted by copyright. Please see publisher’s website instead.
